BAC
CVS icon

Boys Arnold & Co’s CVS Health CVS Stock Holding History

Boys Arnold & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-50,566
Closed -$3M – 46
2020
Q1 		$3M Sell
50,566
-1,001
-2% -$66.8K 0.53% 46
2019
Q4 		$3.83M Sell
51,567
-3,830
-7% -$269K 0.52% 48
2019
Q3 		$3.44M Sell
55,397
-9,570
-15% -$567K 0.51% 49
2019
Q2 		$3.54M Sell
64,967
-4,991
-7% -$269K 0.51% 51
2019
Q1 		$3.77M Sell
69,958
-6,037
-8% -$373K 0.56% 50
2018
Q4 		$4.95M Buy
75,995
+16,801
+28% +$1.25M 0.82% 32
2018
Q3 		$4.71M Buy
59,194
+3,469
+6% +$248K 0.65% 41
2018
Q2 		$3.59M Sell
55,725
-1,187
-2% -$78.2K 0.52% 51
2018
Q1 		$3.71M Sell
56,912
-2,589
-4% -$186K 0.54% 50
2017
Q4 		$4.31M Sell
59,501
-11,887
-17% -$864K 0.65% 42
2017
Q3 		$5.8M Sell
71,388
-5,459
-7% -$432K 0.93% 26
2017
Q2 		$6.18M Sell
76,847
-2,236
-3% -$177K 0.8% 24
2017
Q1 		$6.21M Sell
79,083
-257
-0.3% -$20.5K 0.98% 23
2016
Q4 		$6.26M Sell
79,340
-1,115
-1% -$90.2K 1.04% 22
2016
Q3 		$7.16M Buy
80,455
+184
+0.2% +$17.4K 1.22% 14
2016
Q2 		$7.68M Buy
80,271
+33,512
+72% +$3.34M 1.32% 14
2016
Q1 		$4.85M Sell
46,759
-114,122
-71% -$11.1M 1.92% 9
2015
Q4 		$15.7M Buy
160,881
+80,543
+100% +$7.89M 1.71% 10
2015
Q3 		$7.75M Sell
80,338
-110
-0.1% -$11.6K 1.62% 11
2015
Q2 		$8.44M Sell
80,448
-3,699
-4% -$378K 1.64% 11
2015
Q1 		$8.69M Buy
84,147
+2,310
+3% +$234K 1.65% 11
2014
Q4 		$7.88M Sell
81,837
-2,243
-3% -$198K 1.53% 13
2014
Q3 		$6.69M Sell
84,080
-6,175
-7% -$487K 1.32% 18
2014
Q2 		$6.8M Sell
90,255
-5,737
-6% -$434K 1.18% 24
2014
Q1 		$7.19M Buy
95,992
+1,250
+1% +$88.3K 1.3% 19
2013
Q4 		$6.78M Sell
94,742
-5,841
-6% -$375K 1.29% 21
2013
Q3 		$5.71M Buy
100,583
+640
+0.6% +$38.1K 1.19% 24
2013
Q2 		$5.71M Buy
+99,943
New +$5.79M 1.24% 18

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boys Arnold & Co's CVS Position: Q2 2020 in Review

Boys Arnold & Co sold out of CVS Health (CVS) in Q2 2020, closing a stake of 50,566 shares — an estimated $3M sold.

Boys Arnold & Co first reported a position in CVS in Q2 2013 and held it in 28 quarters. The position peaked at $15.7M in Q4 2015. 1,864 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

  • Boys Arnold & Co reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
  • Boys Arnold & Co sold 50,566 CVS Health shares in Q2 2020, an estimated $3M.
  • Boys Arnold & Co first reported a position in CVS Health in Q2 2013 and held it in 28 quarters.
  • Boys Arnold & Co's CVS Health position peaked at $15.7M in Q4 2015.
  • 1,864 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on Boys Arnold & Co's 13F filing for Q2 2020.